[Guides and standards : systemic treatment algorithm for metastatic or advanced colorectal cancer, palliative intent]
Hindie V
Record ID 32018013282
French
Original Title:
Algorithme de traitement systémique du cancer colorectal métastatique ou avancé, visée palliative
Authors' objectives:
Colorectal cancer (CRC) originates in the cells of the mucosa of the large intestine and
results from the transformation of normal epithelium of the colon or rectum into a
precancerous lesion, and then into an invasive tumour. This gradual process can take
place over a period of 10 to 15 years. Colorectal cancer is generally asymptomatic in its
early stages. It is the fourth most diagnosed cancer in the country and the second leading
cause of cancer-related death.
At the request of the Programme québécois de cancérologie (PQC) of the Ministère de
la Santé et des Services Sociaux (MSSS), the Institut national d’excellence en santé et
en services sociaux (INESSS) has produced an update of the algorithm for the treatment
of metastatic colorectal cancer.
Authors' results and conclusions:
RESULTS: The web format of the algorithm is divided into three main levels: the algorithms which
map the care pathways (level 1), the recommendations for clinical practice (level 2), and
the evidence and discussion (level 3). Clickable links can be used to navigate between
the different levels. This document presents levels 1 and 2.
The main treatments for advanced or metastatic CRC (chemotherapy, targeted therapies,
and immunotherapy) approved by Health Canada are presented in the algorithm with
their indication and reimbursement status. The different care pathways (algorithms;
level 1) are presented according to the status of certain biomarkers (RAS and BRAF), the
location of the primary cancer, and the presence or absence of high microsatellite
instability or deficiency in the mismatch repair system (dMMR/MSI-H):
• RAS and BRAF wild-type, primary cancer in the left colon (from the splenic flexure
to the rectum)
• RAS and BRAF wild-type, primary cancer in the right colon (from the cecum to the
splenic flexure)
• RAS mutated
• BRAF V600E mutation
• dMMR/MSI-H
The preferred treatment sequence is presented, where applicable, as well as other
available options, according to the treatment intent.
The recommendations supporting the proposed clinical practice algorithms at level 1 are
also provided in this document.
Authors' methods:
This algorithm is a decision-making tool containing all of INESSS’s recommendations and
the best available evidence regarding the treatment of CRC in a dynamic web format. It
was developed in collaboration with clinicians and is intended to facilitate the work of
healthcare professionals involved in CRC care pathways. The algorithm is updated on an
ongoing basis.
Details
Project Status:
Completed
URL for project:
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/cancer-colorectal-algorithmes-dinvestigation-de-traitement-et-de-suivi.html
Year Published:
2024
URL for published report:
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/cancer-colorectal-algorithmes-dinvestigation-de-traitement-et-de-suivi.html
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
Canada
Province:
Quebec
MeSH Terms
- Colorectal Neoplasms
- Palliative Care
- Practice Guideline
- Disease Management
- Neoplasm Metastasis
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
Gouvernement du Québec
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.